Carisma Therapeutics

Last updated: December 19, 2023

Saar Gill, Co-Founder
Saar Gill, Co-Founder
Country: USA | Funding: $151.9M (+)

Website: http://carismatx.com/

CARMA TherapeuticsSM is a biotechnology company founded in 2016 to bring the power of adoptive cellular immunotherapy to solid tumor patients through a novel platform using chimeric antigen receptor macrophages (CARMA).